and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Arbutus Biopharma Corporation Stock Price (Quote) NASDAQ:ABUS
$2.88 ( 2.86% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.29 | $2.99 | Tuesday, 5th Jul 2022 ABUS stock ended at $2.88. This is 2.86% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 7.87% from a day low at $2.77 to a day high of $2.99. |
| 90 days | $1.93 | $3.07 | |
| 52 weeks | $1.93 | $6.50 |
Historical Arbutus Biopharma Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $2.79 | $2.99 | $2.77 | $2.88 | 1 571 864 |
| 2022-07-01 | $2.69 | $2.82 | $2.69 | $2.80 | 715 810 |
| 2022-06-30 | $2.62 | $2.76 | $2.62 | $2.71 | 586 547 |
| 2022-06-29 | $2.57 | $2.70 | $2.52 | $2.70 | 553 688 |
| 2022-06-28 | $2.66 | $2.71 | $2.58 | $2.61 | 674 621 |
| 2022-06-27 | $2.80 | $2.86 | $2.63 | $2.68 | 928 077 |
| 2022-06-24 | $2.95 | $2.95 | $2.80 | $2.84 | 2 697 962 |
| 2022-06-23 | $2.75 | $2.94 | $2.72 | $2.92 | 1 222 671 |
| 2022-06-22 | $2.69 | $2.85 | $2.65 | $2.74 | 822 041 |
| 2022-06-21 | $2.70 | $2.86 | $2.68 | $2.72 | 1 331 255 |
| 2022-06-17 | $2.57 | $2.76 | $2.54 | $2.68 | 1 784 357 |
| 2022-06-16 | $2.48 | $2.61 | $2.39 | $2.57 | 1 295 331 |
| 2022-06-15 | $2.44 | $2.61 | $2.42 | $2.55 | 1 110 654 |
| 2022-06-14 | $2.38 | $2.45 | $2.32 | $2.43 | 549 092 |
| 2022-06-13 | $2.42 | $2.45 | $2.29 | $2.38 | 949 193 |
| 2022-06-10 | $2.60 | $2.61 | $2.42 | $2.52 | 812 196 |
| 2022-06-09 | $2.67 | $2.71 | $2.62 | $2.65 | 610 838 |
| 2022-06-08 | $2.63 | $2.82 | $2.63 | $2.68 | 729 094 |
| 2022-06-07 | $2.54 | $2.70 | $2.48 | $2.70 | 582 474 |
| 2022-06-06 | $2.73 | $2.74 | $2.48 | $2.56 | 1 111 354 |
| 2022-06-03 | $2.60 | $2.73 | $2.54 | $2.70 | 749 517 |
| 2022-06-02 | $2.46 | $2.60 | $2.43 | $2.60 | 871 003 |
| 2022-06-01 | $2.43 | $2.56 | $2.41 | $2.46 | 953 846 |
| 2022-05-31 | $2.45 | $2.49 | $2.38 | $2.43 | 1 203 608 |
| 2022-05-27 | $2.32 | $2.50 | $2.27 | $2.48 | 1 075 310 |
| 2022-05-26 | $2.22 | $2.38 | $2.22 | $2.31 | 771 528 |
| 2022-05-25 | $2.19 | $2.27 | $2.17 | $2.25 | 794 302 |
| 2022-05-24 | $2.37 | $2.37 | $2.18 | $2.19 | 1 181 864 |
| 2022-05-23 | $2.44 | $2.47 | $2.34 | $2.40 | 869 960 |
| 2022-05-20 | $2.32 | $2.51 | $2.30 | $2.44 | 1 471 126 |
| 2022-05-19 | $2.31 | $2.43 | $2.28 | $2.34 | 1 275 337 |
| 2022-05-18 | $2.34 | $2.45 | $2.30 | $2.31 | 1 047 592 |
| 2022-05-17 | $2.28 | $2.42 | $2.25 | $2.41 | 1 090 270 |
| 2022-05-16 | $2.27 | $2.38 | $2.22 | $2.26 | 745 559 |
| 2022-05-13 | $2.09 | $2.35 | $2.08 | $2.31 | 1 712 394 |
| 2022-05-12 | $2.02 | $2.17 | $1.97 | $2.06 | 2 151 819 |
| 2022-05-11 | $1.95 | $2.22 | $1.94 | $2.06 | 2 020 862 |
| 2022-05-10 | $2.34 | $2.36 | $1.93 | $1.98 | 3 269 193 |
| 2022-05-09 | $2.46 | $2.47 | $2.22 | $2.23 | 1 467 819 |
| 2022-05-06 | $2.55 | $2.60 | $2.45 | $2.53 | 1 043 530 |
| 2022-05-05 | $2.59 | $2.59 | $2.42 | $2.55 | 1 248 573 |
| 2022-05-04 | $2.42 | $2.50 | $2.28 | $2.49 | 1 059 993 |
| 2022-05-03 | $2.42 | $2.51 | $2.39 | $2.42 | 671 797 |
| 2022-05-02 | $2.37 | $2.49 | $2.33 | $2.44 | 1 357 098 |
| 2022-04-29 | $2.40 | $2.51 | $2.33 | $2.33 | 570 329 |
| 2022-04-28 | $2.46 | $2.49 | $2.26 | $2.43 | 1 395 384 |
| 2022-04-27 | $2.49 | $2.53 | $2.42 | $2.43 | 702 242 |
| 2022-04-26 | $2.57 | $2.62 | $2.48 | $2.48 | 842 652 |
| 2022-04-25 | $2.53 | $2.68 | $2.53 | $2.63 | 1 244 495 |
| 2022-04-22 | $2.48 | $2.59 | $2.45 | $2.57 | 1 633 101 |
Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. It also develops a pipeline of products based on RNA interference therapeutics (RNAi). Its lead candidate is ARB-1467, a multi-component RNAi therapeutic product that is designed for the elimination of HBV surface antigen expression in patients chronically i... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
